Moderna Inc (MRNA)
Operating profit margin
| Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 | Dec 31, 2019 | ||
|---|---|---|---|---|---|---|
| Operating income | US$ in thousands | -4,239,000 | 9,420,000 | 13,296,000 | -763,000 | -546,000 |
| Revenue | US$ in thousands | 6,775,000 | 19,263,000 | 18,471,000 | 803,000 | 60,000 |
| Operating profit margin | -62.57% | 48.90% | 71.98% | -95.02% | -910.00% |
December 31, 2023 calculation
Operating profit margin = Operating income ÷ Revenue
= $-4,239,000K ÷ $6,775,000K
= -62.57%
The operating profit margin of Moderna Inc has shown significant fluctuations over the past five years. In 2023, the operating profit margin was -61.90%, indicating that the company incurred operating losses during that period. This is a stark contrast to the previous year, 2022, when the operating profit margin was a healthy 48.90%, suggesting efficient cost management and revenue generation.
The most notable year for Moderna Inc was 2021, with an impressive operating profit margin of 71.98%, indicating a strong ability to generate profits from its operations. However, in 2020, the company experienced a significant decline with an operating profit margin of -94.99%, signifying substantial operating losses during that period.
The most dramatic change in operating profit margin was observed in 2019, where it stood at a staggering -906.38%, suggesting severe financial challenges and inefficiencies in the company's operations.
Overall, the fluctuating trends in Moderna Inc's operating profit margins over the years indicate varying levels of profitability and operational efficiencies, highlighting the importance of consistent financial and operational performance evaluation and management.
Peer comparison
Dec 31, 2023